These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Substitution of the adenovirus serotype 5 knob with a serotype 3 knob enhances multiple steps in virus replication. Kawakami Y; Li H; Lam JT; Krasnykh V; Curiel DT; Blackwell JL Cancer Res; 2003 Mar; 63(6):1262-9. PubMed ID: 12649186 [TBL] [Abstract][Full Text] [Related]
4. Tropism and transduction of oncolytic adenovirus 5 vectors in cancer therapy: Focus on fiber chimerism and mosaicism, hexon and pIX. Stepanenko AA; Chekhonin VP Virus Res; 2018 Sep; 257():40-51. PubMed ID: 30125593 [TBL] [Abstract][Full Text] [Related]
5. Use of the Syrian hamster as an animal model for oncolytic adenovirus vectors. Thomas MA; Spencer JF; Wold WS Methods Mol Med; 2007; 130():169-83. PubMed ID: 17401172 [TBL] [Abstract][Full Text] [Related]
6. A human adenoviral vector with a chimeric fiber from canine adenovirus type 1 results in novel expanded tropism for cancer gene therapy. Stoff-Khalili MA; Rivera AA; Glasgow JN; Le LP; Stoff A; Everts M; Tsuruta Y; Kawakami Y; Bauerschmitz GJ; Mathis JM; Pereboeva L; Seigal GP; Dall P; Curiel DT Gene Ther; 2005 Dec; 12(23):1696-706. PubMed ID: 16034451 [TBL] [Abstract][Full Text] [Related]
7. Enhanced antitumor efficacy of a novel fiber chimeric oncolytic adenovirus expressing p53 on hepatocellular carcinoma. Chen W; Wu Y; Liu W; Wang G; Wang X; Yang Y; Chen W; Tai Y; Lu M; Qian Q; Zhang Q; Chen G Cancer Lett; 2011 Aug; 307(1):93-103. PubMed ID: 21504839 [TBL] [Abstract][Full Text] [Related]
8. A mosaic fiber adenovirus serotype 5 vector containing reovirus sigma 1 and adenovirus serotype 3 knob fibers increases transduction in an ovarian cancer ex vivo system via a coxsackie and adenovirus receptor-independent pathway. Tsuruta Y; Pereboeva L; Glasgow JN; Rein DT; Kawakami Y; Alvarez RD; Rocconi RP; Siegal GP; Dent P; Fisher PB; Curiel DT Clin Cancer Res; 2007 May; 13(9):2777-83. PubMed ID: 17473211 [TBL] [Abstract][Full Text] [Related]
9. Oncolytic adenovirus based on serotype 3. Hemminki O; Bauerschmitz G; Hemmi S; Lavilla-Alonso S; Diaconu I; Guse K; Koski A; Desmond RA; Lappalainen M; Kanerva A; Cerullo V; Pesonen S; Hemminki A Cancer Gene Ther; 2011 Apr; 18(4):288-96. PubMed ID: 21183947 [TBL] [Abstract][Full Text] [Related]
10. Targeting adenovirus to the serotype 3 receptor increases gene transfer efficiency to ovarian cancer cells. Kanerva A; Mikheeva GV; Krasnykh V; Coolidge CJ; Lam JT; Mahasreshti PJ; Barker SD; Straughn M; Barnes MN; Alvarez RD; Hemminki A; Curiel DT Clin Cancer Res; 2002 Jan; 8(1):275-80. PubMed ID: 11801569 [TBL] [Abstract][Full Text] [Related]
11. Syrian hamster tumor model to study oncolytic Ad5-based vectors. Dhar D; Toth K; Wold WS Methods Mol Biol; 2012; 797():53-63. PubMed ID: 21948468 [TBL] [Abstract][Full Text] [Related]
12. An acute toxicology study with INGN 007, an oncolytic adenovirus vector, in mice and permissive Syrian hamsters; comparisons with wild-type Ad5 and a replication-defective adenovirus vector. Lichtenstein DL; Spencer JF; Doronin K; Patra D; Meyer JM; Shashkova EV; Kuppuswamy M; Dhar D; Thomas MA; Tollefson AE; Zumstein LA; Wold WS; Toth K Cancer Gene Ther; 2009 Aug; 16(8):644-54. PubMed ID: 19197324 [TBL] [Abstract][Full Text] [Related]
13. Replication properties of human adenovirus in vivo and in cultures of primary cells from different animal species. Jogler C; Hoffmann D; Theegarten D; Grunwald T; Uberla K; Wildner O J Virol; 2006 Apr; 80(7):3549-58. PubMed ID: 16537623 [TBL] [Abstract][Full Text] [Related]
14. Syrian hamster as a permissive immunocompetent animal model for the study of oncolytic adenovirus vectors. Thomas MA; Spencer JF; La Regina MC; Dhar D; Tollefson AE; Toth K; Wold WS Cancer Res; 2006 Feb; 66(3):1270-6. PubMed ID: 16452178 [TBL] [Abstract][Full Text] [Related]
15. Targeting adenovirus to CD80 and CD86 receptors increases gene transfer efficiency to malignant glioma cells. Ulasov IV; Rivera AA; Han Y; Curiel DT; Zhu ZB; Lesniak MS J Neurosurg; 2007 Sep; 107(3):617-27. PubMed ID: 17886563 [TBL] [Abstract][Full Text] [Related]
17. Selective targeting of human cells by a chimeric adenovirus vector containing a modified fiber protein. Stevenson SC; Rollence M; Marshall-Neff J; McClelland A J Virol; 1997 Jun; 71(6):4782-90. PubMed ID: 9151872 [TBL] [Abstract][Full Text] [Related]
18. Tropism of human adenovirus type 5-based vectors in swine and their ability to protect against transmissible gastroenteritis coronavirus. Torres JM; Alonso C; Ortega A; Mittal S; Graham F; Enjuanes L J Virol; 1996 Jun; 70(6):3770-80. PubMed ID: 8648712 [TBL] [Abstract][Full Text] [Related]
19. INGN 007, an oncolytic adenovirus vector, replicates in Syrian hamsters but not mice: comparison of biodistribution studies. Ying B; Toth K; Spencer JF; Meyer J; Tollefson AE; Patra D; Dhar D; Shashkova EV; Kuppuswamy M; Doronin K; Thomas MA; Zumstein LA; Wold WS; Lichtenstein DL Cancer Gene Ther; 2009 Aug; 16(8):625-37. PubMed ID: 19197322 [TBL] [Abstract][Full Text] [Related]
20. Combining high selectivity of replication with fiber chimerism for effective adenoviral oncolysis of CAR-negative melanoma cells. Rivera AA; Davydova J; Schierer S; Wang M; Krasnykh V; Yamamoto M; Curiel DT; Nettelbeck DM Gene Ther; 2004 Dec; 11(23):1694-702. PubMed ID: 15496964 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]